ArticleMultiple sclerosis journal - experimental, translational and clinical

Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions.

Enrique Alvarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.